News & Media / Press Releases

WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics

May 8, 2015

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.

Continue Reading

WBB Securities Co-Manages $25 Million Public Offering for TetraLogic

May 1, 2015

WBB Securities is acting as co-manager to a transaction for TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology.

Continue Reading

M&A Mania Infects Generic Drug Companies

April 22, 2015

There are very few assurances in life, but in the field of generic pharmaceuticals, there are three certainties we are about to witness

Continue Reading

Can The Apple Watch Really Keep The Doctor Away?

April 9, 2015

At a little after 12:00 AM Pacific Time consumers will be able to pre-order the Apple Watch online for delivery on April 24th.

Continue Reading

The Three Things Ken Burns Gets Wrong About Cancer

April 3, 2015

Rather than focusing on the noble quest of a few scientists and physicians, we must face the reality that cancer is a business.

Continue Reading

WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference

March 20, 2015

Today WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.

Continue Reading

Nightmare Bacteria And Dirty Scopes: Ignorance And Want In Medicine

February 20, 2015

A deadly strain of antibiotic-resistant bacteria, dubbed “nightmare bacteria” by the head of the Centers for Disease Control and Prevention (CDC), has struck again.

Continue Reading

WBB Securities Co-Manages $84 Million Public Offering for Omeros Corporation

February 4, 2015

WBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.

Continue Reading

Obama’s New Healthcare Proposal: A Precise Vision Or A Political Football

February 4, 2015

When President Obama unveiled his Precision Medicine Initiative, he declared a two-fold challenge.

Continue Reading

WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation

January 15, 2015

CytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities

Continue Reading